Your browser doesn't support javascript.
loading
The Lipid Intensive Drug Therapy for Sepsis Phase II Pilot Clinical Trial.
Guirgis, Faheem W; Black, Lauren Page; Henson, Morgan; Bertrand, Andrew; DeVos, Elizabeth; Ferreira, Jason; Gao, Hanzhi; Wu, Samuel S; Leeuwenburgh, Christiaan; Moldawer, Lyle; Moore, Frederick; Reddy, Srinivasa T.
Afiliação
  • Guirgis FW; Department of Emergency Medicine, University of Florida College of Medicine, Gainesville, FL.
  • Black LP; Department of Emergency Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL.
  • Henson M; Department of Emergency Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL.
  • Bertrand A; Department of Emergency Medicine, University of Florida College of Medicine, Gainesville, FL.
  • DeVos E; Department of Emergency Medicine, Northwestern University, Feinberg School of Medicine, Chicago, IL.
  • Ferreira J; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Florida College of Medicine-Jacksonville, Jacksonville, FL.
  • Gao H; Department of Biostatistics, College of Public Health & Health Professions and College of Medicine, University of Florida, Gainesville, FL.
  • Wu SS; Department of Biostatistics, College of Public Health & Health Professions and College of Medicine, University of Florida, Gainesville, FL.
  • Leeuwenburgh C; Department of Physiology and Aging, University of Florida College of Medicine, Gainesville, FL.
  • Moldawer L; Department of Surgery, University of Florida College of Medicine, Gainesville, FL.
  • Moore F; Department of Surgery, University of Florida College of Medicine, Gainesville, FL.
  • Reddy ST; Department of Medicine, UCLA College of Medicine, Los Angeles, CA.
Crit Care Med ; 52(8): 1183-1193, 2024 Aug 01.
Article em En | MEDLINE | ID: mdl-38488429
ABSTRACT

OBJECTIVES:

Low cholesterol levels in early sepsis patients are associated with mortality. We sought to test if IV lipid emulsion administration to sepsis patients with low cholesterol levels would prevent a decline or increase total cholesterol levels at 48 hours.

DESIGN:

Phase II, adaptive, randomized pilot clinical trial powered for 48 patients.

SETTING:

Emergency department or ICU of an academic medical center. PATIENTS Sepsis patients (first 24 hr) with Sequential Organ Failure Assessment greater than or equal to 4 or shock.

INTERVENTIONS:

Patients meeting study criteria, including screening total cholesterol levels less than or equal to 100 mg/dL or high-density lipoprotein cholesterol (HDL-C) + low-density lipoprotein cholesterol (LDL-C) less than or equal to 70 mg/dL, were randomized to receive one of three doses of lipid emulsion administered twice in 48 hours or no drug (controls). The primary endpoint was a change in serum total cholesterol (48 hr - enrollment) between groups. MEASUREMENTS AND MAIN

RESULTS:

Forty-nine patients were enrolled and randomized. Two patients randomized to lipid emulsion were withdrawn before drug administration. Data for 24 control patients and 23 lipid emulsion patients were analyzed. The mean change in total cholesterol from enrollment to 48 hours was not different between groups and was 5 mg/dL ( sd 20) for lipid emulsion patients, and 2 mg/dL ( sd 18) for control patients ( p = 0.62). The mean changes in HDL-C and LDL-C were similar between groups. Mean change in triglycerides was elevated in lipid emulsion patients (61 mg/dL, sd 87) compared with controls (20 mg/dL, sd 70, p = 0.086). The 48-hour change in SOFA score was -2 (interquartile range [IQR] -4, -1) for control patients and -2 (IQR -3, 0) for lipid emulsion patients ( p = 0.46).

CONCLUSIONS:

Administration of IV lipid emulsion to early sepsis patients with low cholesterol levels did not influence change in cholesterol levels from enrollment to 48 hours.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colesterol / Sepse / Emulsões Gordurosas Intravenosas Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Crit Care Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colesterol / Sepse / Emulsões Gordurosas Intravenosas Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Crit Care Med Ano de publicação: 2024 Tipo de documento: Article